Log in

Relevant bibliographies by topics / Buccal Tablets

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers

Academic literature on the topic 'Buccal Tablets'

Author: Grafiati

Published: 5 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Buccal Tablets.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Buccal Tablets"

1

Webster, Lynn R. "Fentanyl buccal tablets." Expert Opinion on Investigational Drugs 15, no. 11 (2006): 1469–73. http://dx.doi.org/10.1517/13543784.15.11.1469.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

GUPTA, SANJAY KUMAR, Sradhanjali Patra, and Syed Adnan Akber. "FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF ALENDRONATE BUCCAL TABLETS." Journal of Drug Delivery and Therapeutics 9, no. 4-s (2019): 363–69. http://dx.doi.org/10.22270/jddt.v9i4-s.3253.

Full text

Abstract:

The aim of this work was to develop a mucoadhesive buccal tablet for the buccal delivery of the alendronate via buccal mucosa. Buccal tablets of alendronate are designed to release drug at mucosal site for extended period of time without wash out of drug by saliva. Alendronate sodium is a bisphosphonates which has antiresorptive effect which is implicated in the prophylaxis and treatment of osteoporosis. Sodium alginate, ethyl cellulose and carbopol were selected as mucoadhesive polymers on the basis of their matrix forming properties. The objective of the study is to improve the bioavailabili

APA, Harvard, Vancouver, ISO, and other styles

3

Gawai, Nitin, and Zahid Zaheer. "FORMUALTION AND DEVELOPMENT OF MUCOADHESIVE SUSTAINED RELEASE BUCCAL TABLETS AND PATCHES OF 5-FLUOROURACIL USING DIFFERENT POLYMERS." Asian Journal of Pharmaceutical and Clinical Research 11, no. 5 (2018): 174. http://dx.doi.org/10.22159/ajpcr.2018.v11i5.20241.

Full text

Abstract:

Objective: The present research study was undertaken to formulate mucoadhesive sustained release buccal tablets and patches of 5-fluorouracil (5-FU).Method: For the research experiment work design expert software version 10, stat-ease, Inc. has been used. A 32 full factorial design was selected for the formulation of the buccal tablet as well as buccal patches. In this research work, formulated tablets and patches using different polymers such as carbopol 974p, polyvinylpyrrolidone-K 30, sodium deoxycholate, microcrystalline cellulose, and polyvinyl alcohol. An after formulation of batches for

APA, Harvard, Vancouver, ISO, and other styles

4

Singh, Shubham, Anand Chaurasia, Naveen Gupta, and Dharmendra Singh Rajput. "Effect of Formulation Parameters on Enalapril Maleate Mucoadhesive Buccal Tablet Using Quality by Design (QbD) Approach." Chinese Journal of Applied Physiology 40 (2024): e20240003. http://dx.doi.org/10.62958/j.cjap.2024.003.

Full text

Abstract:

The buccal route has great prospects and possible benefits for the administration of drugs systemically. The present study involves designing, developing and optimising the buccal tablet formulation of Enalapril Maleate (EM) by using the QbD approach. We prepared the EM buccal tablets using the dry granulation method. In the QTPP profile, the CQAs for EM buccal tablets are Mucoadhesive strength, swelling index and drug release (dependent variables); the CMAs identified for EM buccal tablets were Carbopol 934P, HPMC-K100M and chitosan (independent variables). Diluent quantity, blending time and

APA, Harvard, Vancouver, ISO, and other styles

5

Omer, Mohammed, and S. M. Shahidulla. "Formulation and Evaluation of Mucoadhesive Bilayered Buccal Tablet of Ziprasidone Hydrochloride." Journal of Drug Delivery and Therapeutics 12, no. 5-S (2022): 174–80. http://dx.doi.org/10.22270/jddt.v12i5-s.5757.

Full text

Abstract:

The present project was carried out to formulate and evaluate the mucoadhesive bilayered buccal tablet of Ziprasidone Hcl. Ziprasidone HCl is an antipsychotic agent with half-life of about 2hrs and shows extensive metabolism i.e the drug concentration is < 5% after elimination in the body. The formulations (F1 to F6) were developed which comprises of polymers such as Hydroxypropyl methyl cellulose (HPMC K-15), Polyvinyl pyrollidine (PVP K-30) in various concentrations along with carbopol to achieve the desired characteristics. Mucoadhesive bilayered buccal tablets were fabricated with the a

APA, Harvard, Vancouver, ISO, and other styles

6

Durfee, Steven, John Messina, and Raj Khankari. "Fentanyl Effervescent Buccal Tablets." American Journal of Drug Delivery 4, no. 1 (2006): 1–5. http://dx.doi.org/10.2165/00137696-200604010-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Samanthula, Kumara Swamy, Agaiah Goud Bairi, and CB Mahendra Kumar. "Muco-adhesive buccal tablets of candesartan cilexetil for oral delivery: preparation, in-vitro and ex-vivo evaluation." Journal of Drug Delivery and Therapeutics 11, no. 1-s (2021): 35–42. http://dx.doi.org/10.22270/jddt.v11i1-s.4547.

Full text

Abstract:

Candesartan cilexetil (CC) is an angiotensin II-receptor blocker (ARB). The antihypertensive effect of CC 4-16 mg/day was as great as that of other once-daily dosage regimens. Candesartan cilexetil has high first-pass metabolism and low oral bioavailability. The bioavailability of such drugs may be significantly improved if delivered through the buccal route; hence mucosal delivery is one of the alternative methods of systemic drug delivery. This study’s objective was to develop mucoadhesive buccal tablets of candesartan cilexetil using carbopol-934P, hydroxyl propyl methyl cellulose (HPMC), E

APA, Harvard, Vancouver, ISO, and other styles

8

Kaundal, Ankaj, Pravin Kumar, Rajendra Awasthi, and Giriraj T. Kulkarni. "Development of Mucoadhesive Buccal Drug Delivery System of Propranolol Hydrochloride Using Aster ericoides Mucilage." Drug Delivery Letters 10, no. 2 (2020): 133–48. http://dx.doi.org/10.2174/2210303109666191010164201.

Full text

Abstract:

Aim: The study was aimed to develop mucoadhesive buccal tablets using Aster ericoides leaves mucilage. Background : Mucilages are naturally occurring high-molecular-weight polyuronides, which have been extensively studied for their application in different pharmaceutical dosage forms. Objective: The objective of the present research was to establish the mucilage isolated from the leaves of Aster ericoides as an excipient for the formulation of the mucoadhesive buccal tablet. Method: The mucilage was isolated from the leaves of Aster ericoides by maceration, precipitated with acetone and charac

APA, Harvard, Vancouver, ISO, and other styles

9

Rachana, Sarawade1 Deepak Rathod2. "Formulation And Evaluation of Novel Drug Delivery System Containing Anti Parkinson's Agent." International Journal of Pharmaceutical Sciences 2, no. 12 (2024): 1530–55. https://doi.org/10.5281/zenodo.14406680.

Full text

Abstract:

Introduction : This study explores the use of buccal administration as a potential route for delivering Levodopa (LD) in the treatment of Parkinson's disease (PD). Parkinson's disease is a neurodegenerative disease that affects dopaminergic neurons, leading to a deficiency of dopamine. The current treatment of choice is levodopa, but it has low oral bioavailability and poor brain uptake. The methodology involves the formulation of buccal mucoadhesive tablets that attach to the buccal mucosa. The study highlights the advantages of the formulation by increasing bioavailability and bypassing of g

APA, Harvard, Vancouver, ISO, and other styles

10

Nishigandha, Pandurang Gite1* Vinayak Munde2. "Formulation And Evaluation Of Mucoadhesive Buccal Tablet Of Favipiravir." International Journal in Pharmaceutical Sciences 2, no. 8 (2024): 3733–54. https://doi.org/10.5281/zenodo.13371490.

Full text

Abstract:

This research work investigates the formulation and evaluation of mucoadhesive buccal tablets containing Favipiravir, an antiviral medication with proven efficacy against various RNA viruses, including influenza and certain strains of coronaviruses. The objective of this study is to develop a novel drug delivery system that enhances the bioavailability and therapeutic efficacy of Favipiravir through buccal administration, thereby addressing the limitations associated with conventional oral dosage forms. The formulation development phase involves the selection of suitable mucoadhesive polymers

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Buccal Tablets"

1

Park, Calum R. "Mucoadhesive buccal tablets for the delivery of nicotine and Î”9-tetrahydrocannabinol." Thesis, Robert Gordon University, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.408996.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Owens, Tim Sadley. "Development and Evaluation of Extended Release Bioadhesive Sodium Fluoride Tablets." University of Cincinnati / OhioLINK, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1100715863.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Al-Ani, Enas Atallah. "Towards a more efficacious treatment for oropharyngeal candidiasis (OPC) : hydrogel-forming tablets for the controlled release delivery of chlorhexidine diacetate." Thesis, University of Wolverhampton, 2018. http://hdl.handle.net/2436/621861.

Full text

Abstract:

Oropharyngeal candidiasis is a localised infection in the oropharynx region caused by Candida species, predominately C. albicans. It is commonly spread among immunocompromised patients and aggravated by hyposalivation or xerostomia. Current treatment is by systemic antifungals, which might be accompanied by gastrointestinal tract disorders, headache, allergic reactions and drug interactions or Candida becoming resistant to them. In the present work, the anti-candida activity of chlorhexidine diacetate (CHD) was tested as the drug of choice, it has no systemic side effects and microorganisms do

APA, Harvard, Vancouver, ISO, and other styles

4

Iyire, Affiong. "Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology." Thesis, Aston University, 2016. http://publications.aston.ac.uk/30165/.

Full text

Abstract:

Buccal drug delivery combines the advantage of enhanced patient acceptance/ compliance of oral delivery, with overcoming drug degradation and poor absorption in the gastro intestinal tract (GIT), especially for large molecule therapeutics, such as insulin. Orally disintegrating tablets (ODTs) that dissolve rapidly in the mouth, are gaining widespread popularity, especially with extreme populations, including children and the elderly. This project unifies the advantages of buccal drug delivery with that of ODTs, with the view to developing a non-invasive delivery system for proteins like insuli

APA, Harvard, Vancouver, ISO, and other styles

5

Bouckaert, Stefan. "Ontwikkeling en evaluatie van een buccale bioadhesieve tablet voor lokale therapie /." Gent : Univ., Fac. van de Farmaceut. Wetenschappen, 1994. http://www.gbv.de/dms/bs/toc/211006491.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Buccal Tablets"

1

Formulation and Evaluation of Antifungal Buccal Tablets. Independently Published, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Buccal Tablets"

1

"Polysaccharide-Based Mucoadhesive Buccal Tablets." In Modified-Release Drug Delivery Technology. CRC Press, 2002. http://dx.doi.org/10.1201/9780203910337-36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Johnston, Thomas, Ashim Mitra, and Hemant Alur. "Polysaccharide-Based Mucoadhesive Buccal Tablets." In Drugs and the Pharmaceutical Sciences. Informa Healthcare, 2002. http://dx.doi.org/10.1201/9780203910337.ch33.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

M, Abirami, and Rajesh Kumar N. "PHARMACEUTICAL PREPARATION AND DRUG DELIVERY." In Futuristic Trends in Pharmacy & Nursing Volume 3 Book 4. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bipn4p6ch4.

Full text

Abstract:

Pharmaceutical preparations are medicinal preparations that are used in the treatment of various diseases. various dosage forms are necessary to achieve a predictable therapeutic response to a drug product contained in a formulation. Medicinal preparations are available in various dosage forms such as liquids, tablets, capsules, suppositories, Inhalers, topical dosage forms, drops, injections, patches, and buccal tablets. Drug delivery refers to the approaches, formulations, production techniques, storage systems, and technologies used to transfer a pharmaceutical molecule to its targeted ther

APA, Harvard, Vancouver, ISO, and other styles

4

Shwetha, K., and B. V. Basavaraj. "Optimization of Vanillin Crosslinked Chitosan/Polycarbophil Superporous Hydrogel Hybrids Containing Tablets for Regulated Drug Delivery." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00523.

Full text

Abstract:

Polysaccharides are most sustainable building blocks with improved characteristics for formulation of superporous hydrogels (SPH). Present research work emphasis on development and optimization of tablets comprising vanillin crosslinked chitosan/polycarbophil (CVP) SPH hybrids for regulated drug delivery. The formulation of CVP SPH hybrids were prepared using microwave irradiation with different concentrations of chitosan (polymer), vanillin (crosslinking agent) and polycarbophil (hybrid agent). Resultant formulation was subjected to FTIR, DSC, TGA, SEM and NMR characterization. Prepared CVP h

APA, Harvard, Vancouver, ISO, and other styles

5

Pentu, Narendra, Manikanta Murahari, and G. Narayana Murthy. "Formulation of Candisartan Mucoadhesive Buccal Tablets After Improving the Solubility by Solid Dispersion and Inclusion Complex Methods." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00427.

Full text

Abstract:

This research work aimed to develop and evaluate the buccal tablets of Candesartan using various Mucoadhesive polymers viz. Hydroxy Propyl Methyl Cellulose (HPMC K4M), Sodium Carboxy methyl cellulose (Sodium CMC), Sodium alginate individually and in combination. Candesartan is an angiotensin II receptor blocker (ARB) used in the treatment of hypertension. It shows the oral bioavailability of 15% due to the first-pass metabolism and has a biological half-life of approximately 9hrs. It is poorly absorbed after oral administration, and having poor solubility and wettability leads to poor dissolut

APA, Harvard, Vancouver, ISO, and other styles

6

Ram*, Dr Darshit, Dr Santosh Kirtane, and Dr Dhara Chavda. "THIN FILMS: NOVEL ASPECTS OF DRUG DELIVERY." In Emerging Pharmaceutical Sciences: Today and Tomorrow. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/nbennurch329.

Full text

Abstract:

These days, scientists are concentrating their efforts on creating novel dosage forms for thin films in the pharmaceutical industry. Compared to typical dose forms, thin film has become an uncommon dosage type. Thin film has various benefits, including ease of administration, rapid dose release, and patient convenience, all of which make it an excellent choice for medication delivery. This delivery mechanism has been used via a variety of channels, including transdermal, buccal, ocular and oral for both local and systemic movement. Effective film layout necessitates a thorough understanding of

APA, Harvard, Vancouver, ISO, and other styles

7

"Slowly Disintegrating Buccal Mucoadhesive Plain-Tablet (S-DBMP-T) and Buccal Covered-Tablet System (BCTS)." In Modified-Release Drug Delivery Technology. CRC Press, 2002. http://dx.doi.org/10.1201/9780203910337-33.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Iga, Katsumi. "Slowly Disintegrating Buccal Mucoadhesive Plain-Tablet (S-DBMP-T) and Buccal Covered- Tablet System (BCTS)." In Drugs and the Pharmaceutical Sciences. Informa Healthcare, 2002. http://dx.doi.org/10.1201/9780203910337.ch30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

"Table of Contents." In La historia clínica médico-bucal. Editorial Unimagdalena, 2025. https://doi.org/10.2307/jj.30347870.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fudala, Paul J., and Anne Cramer Andorn. "Use of Buprenorphine for the Treatment of Opioid Use Disorder." In Substance Use Disorders. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190920197.003.0009.

Full text

Abstract:

Buprenorphine is a mu-opioid partial agonist that was first developed as a parenteral analgesic and subsequently as a treatment for opioid dependence. In the United States, the first two products approved by the US Food and Drug Administration (in 2002) for the latter indication were buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) tablet formulations for sublingual administration. Since that time, additional products for both sublingual and buccal administration have also been approved, as well as a subcutaneous injection for once-monthly administration for the treatment of moder

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Buccal Tablets"

1

Kurcubic, Ivana, and Jelena Đuriš. "Influence of experimental model, active substance and polymer type on mucoadhesive properties of buccal tablets." In II. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2020. http://dx.doi.org/10.14232/syrptbrs.2020.op6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ranganathan, Venkatalakshmi, Yeo Pei Xia, Gooi Mei Seong, Gan Li Ting, and Ravi Sheshala. "Metoprolol Tartrate Delivery From Mucoadhesive Buccal Tablet." In Annual International Conference on Pharmacology and Pharmaceutical Sciences. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2345-783x_pharma14.51.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sulukdjian, A., D. Nguyen, V. Luciani, A. Chanlon, and N. Moreau. "Intérêt de l’indométacine comme traitement d’épreuve des céphalées hémi-faciales : aspects cliniques et pharmacologiques." In 66ème Congrès de la SFCO. EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603015.

Full text

Abstract:

Intérêt de l’indométacine comme traitement d’épreuve des céphalées hémi-faciales : aspects cliniques et pharmacologiques Arek SULUKDJIAN1, Diane NGUYEN2, Vanina LUCIANI3, Audrey CHANLON2, Nathan MOREAU4,5 1- Etudiant en 5ème année de chirurgie dentaire, Faculté de Chirurgie dentaire, Université Paris Descartes 2 - Praticien attaché, consultation de diagnostic et traitement des douleurs chroniques orofaciales, service de médecine bucco- dentaire, Hôpital Bretonneau, AP-HP, Paris 3 - Etudiante en 6ème année de chirurgie dentaire, Faculté de Chirurgie dentaire, Université Paris Descartes 4 - Resp

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!